Jerome Dvonch
Director of Finance/CFO en SONOMA PHARMACEUTICALS, INC. .
Fortuna: 2 574 $ al 31/03/2024
Perfil
Jerome J.
Dvonch is currently the Chief Financial Officer at Sonoma Pharmaceuticals, Inc. He previously held financial positions at Protein Design Labs, Exelixis, NeoGenomics Laboratories, and PharmChem, Inc. He also served as the Controller and SVP-Finance & Accounting at Spine Center Atlanta.
Dvonch holds an MBA from the University of Rochester and an undergraduate degree from Niagara University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 29/12/2023 | 15 505 ( 0.10% ) | 2 574 $ | 31/03/2024 |
Cargos activos de Jerome Dvonch
| Empresas | Cargo | Inicio |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Director of Finance/CFO | 08/09/2020 |
Antiguos cargos conocidos de Jerome Dvonch.
| Empresas | Cargo | Fin |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Director of Finance/CFO | 03/10/2022 |
NeoGenomics Laboratories, Inc.
 NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Director of Finance/CFO | 01/07/2015 |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Corporate Officer/Principal | 01/07/2005 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01/06/2004 |
| Spine Center Atlanta | Comptroller/Controller/Auditor | - |
Formación de Jerome Dvonch.
| Rochester Christian University | Masters Business Admin |
| Niagara University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| PHARMCHEM, INC. | Health Services |
| NEOGENOMICS, INC. | Health Services |
| EXELIXIS, INC. | Health Technology |
| SONOMA PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Health Services |
| Spine Center Atlanta |
- Bolsa de valores
- Insiders
- Jerome Dvonch
